Jonathan Bleeker

4.8k total citations · 2 hit papers
35 papers, 2.0k citations indexed

About

Jonathan Bleeker is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Jonathan Bleeker has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Hematology. Recurrent topics in Jonathan Bleeker's work include Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). Jonathan Bleeker is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). Jonathan Bleeker collaborates with scholars based in United States, Chile and Japan. Jonathan Bleeker's co-authors include Guido Cavaletti, Thomas J. Smith, Nina D. Wagner‐Johnston, Cynthia Chauhan, Bryan P. Schneider, Mary Lou Smith, Elizabeth Smith, Maryam B. Lustberg, Charles L. Loprinzi and Dawn L. Hershman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Jonathan Bleeker

32 papers receiving 2.0k citations

Hit Papers

Prevention and Management of Chemotherapy-Induced Periphe... 2014 2026 2018 2022 2014 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
    2014 887 citations Dawn L. Hershman, Christina Lacchetti et al. Journal of Clinical Oncology profile →
  2. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
    2020 615 citations Charles L. Loprinzi, Christina Lacchetti et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Bleeker United States 12 1.5k 561 534 384 376 35 2.0k
Nguyet Le‐Lindqwister United States 16 1.1k 0.7× 445 0.8× 482 0.9× 217 0.6× 299 0.8× 29 1.6k
Roser Velasco Spain 27 1.4k 0.9× 441 0.8× 267 0.5× 403 1.0× 401 1.1× 72 2.0k
Shelby A. Terstriep United States 8 836 0.5× 323 0.6× 243 0.5× 153 0.4× 191 0.5× 17 1.2k
Bassam Mattar United States 16 1.1k 0.7× 187 0.3× 224 0.4× 484 1.3× 105 0.3× 36 1.9k
Danielle Awad United States 11 829 0.5× 228 0.4× 143 0.3× 136 0.4× 180 0.5× 22 1.2k
Jeffrey K. Giguere United States 22 1.4k 0.9× 116 0.2× 185 0.3× 795 2.1× 59 0.2× 66 2.2k
Roberta J. Secrest United States 16 500 0.3× 734 1.3× 380 0.7× 136 0.4× 142 0.4× 27 2.5k
Shefali Agarwal United States 20 412 0.3× 173 0.3× 182 0.3× 146 0.4× 44 0.1× 48 1.2k
Huaien Zheng Canada 15 286 0.2× 47 0.1× 186 0.3× 196 0.5× 117 0.3× 25 1.1k
Enrico Selvi Italy 26 88 0.1× 96 0.2× 143 0.3× 192 0.5× 45 0.1× 64 1.6k

Countries citing papers authored by Jonathan Bleeker

Since Specialization
Citations

This map shows the geographic impact of Jonathan Bleeker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Bleeker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Bleeker more than expected).

Fields of papers citing papers by Jonathan Bleeker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Bleeker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Bleeker. The network helps show where Jonathan Bleeker may publish in the future.

Co-authorship network of co-authors of Jonathan Bleeker

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Bleeker. A scholar is included among the top collaborators of Jonathan Bleeker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Bleeker. Jonathan Bleeker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powell, Steven, Jonathan Bleeker, Christopher Sumey, et al.. (2023). Expanding rural access to phase I clinical trials.. Journal of Clinical Oncology. 41(16_suppl). e18525–e18525. 1 indexed citations
2.
Abdallah, Mohamed, Ashwani K. Singal, Chencheng Xie, et al.. (2022). Metastatic tumors to the pancreas: Balancing clinical impression with cytology findings. Annals of Hepato-Biliary-Pancreatic Surgery. 26(1). 91–97. 1 indexed citations
3.
Gangat, Naseema, et al.. (2022). Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia. Haematologica. 107(10). 2523–2526. 9 indexed citations
4.
Özer, Muhammet, Syed Mohammad Ali Kazmi, Nina N. Sanford, et al.. (2020). Distinct Clinical Characteristics in Young-Onset Pancreatic Neuroendocrine Tumor. Cancers. 12(9). 2501–2501. 7 indexed citations
5.
Loprinzi, Charles L., Christina Lacchetti, Jonathan Bleeker, et al.. (2020). Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. Journal of Clinical Oncology. 38(28). 3325–3348. 615 indexed citations breakdown →
6.
Dudek, Arkadiusz Z., Li Liu, James H. Fischer, et al.. (2020). Phase 1 study of TTC-352 in patients with metastatic breast cancer progressing on endocrine and CDK4/6 inhibitor therapy. Breast Cancer Research and Treatment. 183(3). 617–627. 16 indexed citations
7.
Kazmi, Syed Mohammad Ali, Nina N. Sanford, Todd A. Aguilera, et al.. (2020). Distinct clinical characteristics of young-onset pancreatic cancer patients.. Journal of Clinical Oncology. 38(4_suppl). 674–674. 1 indexed citations
8.
Bleeker, Jonathan, Christopher Sumey, Steven Powell, et al.. (2020). Implementation of a standardized approach to borderline resectable pancreatic cancer in a multisite community oncology program. Surgery Open Science. 2(4). 25–31. 1 indexed citations
9.
Bleeker, Jonathan, et al.. (2020). Prognostic implications of tumor sidedness in colorectal cancer patients in South Dakota, 2006-2015.. Journal of Clinical Oncology. 38(4_suppl). 46–46. 1 indexed citations
10.
Ellithi, Moataz, et al.. (2020). Complement C3 mutation causing atypical hemolytic uremic syndrome successfully treated with eculizumab. Hematology Transfusion and Cell Therapy. 43(3). 364–367. 1 indexed citations
11.
Wainberg, Zev A., Harry H. Yoon, Daniel V.T. Catenacci, et al.. (2019). Efficacy and safety of pembrolizumab (pembro) alone or in combination with chemotherapy (chemo) in patients (pts) with advanced gastric or gastroesophageal (G/GEJ) cancer: Long-term follow up from KEYNOTE-059.. Journal of Clinical Oncology. 37(15_suppl). 4009–4009. 13 indexed citations
12.
Hayes, Sharonne N., et al.. (2019). Extranodal Rosai-Dorfman Disease Presenting as a Pericardial Mass and Constrictive Pericarditis. SHILAP Revista de lepidopterología. 1(4). 643–647. 1 indexed citations
13.
O’Regan, Ruth, Jasgit C. Sachdev, Jonathan Bleeker, et al.. (2019). Abstract CT051: Phase I study of TTC-352 in patients with estrogen receptor-positive metastatic breast cancer. Clinical Trials. CT051–CT051. 1 indexed citations
14.
Bleeker, Jonathan, et al.. (2018). Epstein-Barr Virus Positive Mucocutaneous Ulcer: A Case Report.. PubMed. 71(6). 252–255. 7 indexed citations
15.
Wainberg, Zev A., Shadia I. Jalal, Kei Muro, et al.. (2017). KEYNOTE-059 Update: Efficacy and safety of pembrolizumab alone or in combination with chemotherapy in patients with advanced gastric or gastroesophageal (G/GEJ) cancer. Annals of Oncology. 28. v616–v617. 30 indexed citations
16.
Gustafson, Michael P., Yi Lin, Jonathan Bleeker, et al.. (2015). Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma. Clinical Cancer Research. 21(18). 4224–4233. 38 indexed citations
17.
Liu, Shiquan, Ali Jassim, Jonathan Bleeker, et al.. (2015). Histopathological Features of Aneurysmal Bone Cyst of the Temporal Bone – A Case Report and Review of Literature. North American Journal of Medicine and Science. 8(1). 1 indexed citations
18.
Bleeker, Jonathan, et al.. (2012). Treatment‐refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs. American Journal of Hematology. 87(7). 703–706. 5 indexed citations
19.
Bleeker, Jonathan, Morie A. Gertz, Patricia A. Pellikka, et al.. (2012). Evaluation of pretransplant factors predicting cardiac dysfunction following high‐dose melphalan conditioning and autologous peripheral blood stem cell transplantation. European Journal Of Haematology. 89(3). 228–235. 11 indexed citations
20.
Bleeker, Jonathan, et al.. (2012). Response to Alemtuzumab in FIP1L1/PDGFRA-Negative Hypereosinophilic Myocarditis on Serial Cardiac Magnetic Resonance Imaging. Journal of the American College of Cardiology. 59(4). 430–430. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nguyet Le‐Lindqwister Breakdown of academic impact, for papers by Roser Velasco Breakdown of academic impact, for papers by Shelby A. Terstriep Breakdown of academic impact, for papers by Bassam Mattar Breakdown of academic impact, for papers by Danielle Awad Breakdown of academic impact, for papers by Jeffrey K. Giguere Breakdown of academic impact, for papers by Roberta J. Secrest Breakdown of academic impact, for papers by Shefali Agarwal Breakdown of academic impact, for papers by Huaien Zheng Breakdown of academic impact, for papers by Enrico Selvi
Rankless by CCL
2026